OGN vs. GSK
Compare and contrast key facts about Organon & Co. (OGN) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or GSK.
Correlation
The correlation between OGN and GSK is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OGN vs. GSK - Performance Comparison
Key characteristics
OGN:
0.10
GSK:
-0.58
OGN:
0.41
GSK:
-0.69
OGN:
1.05
GSK:
0.91
OGN:
0.06
GSK:
-0.45
OGN:
0.22
GSK:
-0.96
OGN:
16.78%
GSK:
13.43%
OGN:
35.82%
GSK:
22.07%
OGN:
-69.56%
GSK:
-55.21%
OGN:
-52.22%
GSK:
-25.42%
Fundamentals
OGN:
$4.05B
GSK:
$66.92B
OGN:
$5.05
GSK:
$1.48
OGN:
3.11
GSK:
22.16
OGN:
$4.81B
GSK:
$23.26B
OGN:
$2.82B
GSK:
$16.84B
OGN:
$1.31B
GSK:
$6.82B
Returns By Period
In the year-to-date period, OGN achieves a 8.45% return, which is significantly higher than GSK's -1.12% return.
OGN
8.45%
9.55%
-20.37%
8.11%
N/A
N/A
GSK
-1.12%
-2.31%
-13.26%
-12.62%
-3.00%
2.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. GSK — Risk-Adjusted Performance Rank
OGN
GSK
OGN vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OGN vs. GSK - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 6.92%, more than GSK's 4.66% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 6.92% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 4.66% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
Drawdowns
OGN vs. GSK - Drawdown Comparison
The maximum OGN drawdown since its inception was -69.56%, which is greater than GSK's maximum drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for OGN and GSK. For additional features, visit the drawdowns tool.
Volatility
OGN vs. GSK - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 8.56% compared to GlaxoSmithKline plc (GSK) at 6.06%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OGN vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities